(Q36593757)

15 August 2017

1 reference

title

Immune privilege in sites of chronic infection: Leishmania and regulatory T cells (English)

1 reference

15 August 2017

Nathan Peters

1

1 reference

PubMed ID

16972903

15 August 2017

David Sacks

series ordinal

2

1 reference

15 August 2017

1 October 2006

1 reference

15 August 2017

Immunological Reviews

1 reference

15 August 2017

213

1 reference

15 August 2017

159-179

1 reference

Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Defective stimulus-response coupling in human monocytes infected with Leishmania donovani is associated with altered activation and translocation of protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

The lipophosphoglycan of Leishmania and macrophage protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Transbilayer inhibition of protein kinase C by the lipophosphoglycan from Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Nonopsonic phagocytosis of zymosan and Mycobacterium kansasii by CR3 (CD11b/CD18) involves distinct molecular determinants and is or is not coupled with NADPH oxidase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Specific recognition and cleavage of galectin-3 by Leishmania major through species-specific polygalactose epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

God must love galectins; he made so many of them

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Glycosylation, immunity, and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Mimicry of apoptotic cells by exposing phosphatidylserine participates in the establishment of amastigotes of Leishmania (L) amazonensis in mammalian hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Modulation of phagolysosome biogenesis by the lipophosphoglycan of Leishmania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Fusion of Host Cell Secondary Lysosomes with the Parasitophorous Vacuoles ofLeishmania mexicana-inlected Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Leishmania promastigotes require lipophosphoglycan to actively modulate the fusion properties of phagosomes at an early step of phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Subversion of a young phagosome: the survival strategies of intracellular pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Leishmania donovani lipophosphoglycan disrupts phagosome microdomains in J774 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

IgA Fc receptor (FcalphaR) cross-linking recruits tyrosine kinases, phosphoinositide kinases and serine/threonine kinases to glycolipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Glycoconjugates in Leishmania infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Persistence without pathology in phosphoglycan-deficient Leishmania major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Leishmania-induced inhibition of macrophage antigen presentation analyzed at the single-cell level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma-triggered JAK2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Leishmania donovani-induced expression of suppressor of cytokine signaling 3 in human macrophages: a novel mechanism for intracellular parasite suppression of activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Leishmania inhibits STAT1-mediated IFN-gamma signaling in macrophages: increased tyrosine phosphorylation of dominant negative STAT1beta by Leishmania mexicana.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Dendritic cells and host resistance to infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll‐like receptor 2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Myd88-dependent in vivo maturation of splenic dendritic cells induced by Leishmania donovani and other Leishmania species

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Leishmania amazonensis-dendritic cell interactions in vitro and the priming of parasite-specific CD4(+) T cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Hierarchy of susceptibility of dendritic cell subsets to infection by Leishmania major: inverse relationship to interleukin-12 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Leishmania major modulates chemokine and chemokine receptor expression by dendritic cells and affects their migratory capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Leishmania major promastigotes inhibit dendritic cell motility in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 c

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

The immunology of susceptibility and resistance to Leishmania major in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

IL-4-deficient Balb/c mice resist infection with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Selective activation and expansion of high-affinity CD4+ T cells in resistant mice upon infection with Leishmania major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Rapid expansion and IL-4 expression by Leishmania-specific naive helper T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

The Leishmania major LACK antigen with an immunodominant epitope at amino acids 156 to 173 is not required for early Th2 development in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Recombinant interleukin 12 cures mice infected with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Interleukin-4 receptor alpha-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

A role for the immunological synapse in lineage commitment of CD4 lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

CD4+ T cell polarization in mice is modulated by strain-specific major histocompatibility complex-independent differences within dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

The importance of CD11b+ dendritic cells in CD4+ T cell activation in vivo: with help from interleukin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Correlates of Leishmania-specific immunity in the clinical spectrum of infection with Leishmania chagasi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

IL-10 mediates susceptibility to Leishmania donovani infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Regulatory T cells and intestinal homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Regulatory T cells and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Interleukin 2 signaling is required for CD4(+) regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Natural regulatory T cells and self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Interleukin-10 in the regulation of T cell-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Type 1 T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Regulatory T cells and mechanisms of immune system control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Natural and induced regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10(-/-) setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Breaking tolerance to nickel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Peripheral autoantigen induces regulatory T cells that prevent autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

IL-4 Rapidly Produced by Vβ4 Vα8 CD4+ T Cells Instructs Th2 Development and Susceptibility to Leishmania major in BALB/c Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Inflammatory arthritis and dermatitis in thymectomized, CD25+ cell-depleted adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

The third component of complement (C3) is responsible for the intracellular survival of Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

Immunosuppressive effects of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00432.X

10.1111/J.1600-065X.2006.00432.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

16972903